TY - JOUR
T1 - Home blood pressure-centered approach – from digital health to medical practice
T2 - HOPE Asia Network consensus statement 2023
AU - Kario, Kazuomi
AU - Tomitani, Naoko
AU - Wang, Tzung Dau
AU - Park, Sungha
AU - Li, Yan
AU - Shin, Jinho
AU - Tsoi, Kelvin
AU - Chen, Chen Huan
AU - Cheng, Hao Min
AU - Siddique, Saulat
AU - Turana, Yuda
AU - Buranakitjaroen, Peera
AU - Van Huynh, Minh
AU - Nailes, Jennifer
AU - Sison, Jorge
AU - Soenarta, Arieska Ann
AU - Sogunuru, Guru Prasad
AU - Sukonthasarn, Apichard
AU - Tay, Jam Chin
AU - Teo, Boon Wee
AU - Verma, Narsingh
AU - Zhang, Yuqing
AU - Schlaich, Markus
AU - Nagai, Michiaki
AU - Fujiwara, Takeshi
AU - Hoshide, Satoshi
AU - Chia, Yook Chin
AU - Wang, Ji Guang
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to The Japanese Society of Hypertension.
PY - 2023/12
Y1 - 2023/12
N2 - Recent innovations in digital technology have enabled the simultaneous accumulation, and the linking and analysis of time-series big data relating to several factors that influence blood pressure (BP), including biological indicators, physical activity, and environmental information. Various approaches can be used to monitor BP: in the office/clinic; at home; 24-h ambulatory recording; or with wearable and cuffless devices. Of these, home BP monitoring is a reliable and convenient method, and is recommended for hypertension management by current national and international guidelines. This recommendation is based on evidence showing that home BP is an important predictor of cardiovascular, cerebrovascular and kidney disease in patients with hypertension. In addition, lifetime personalized health record (PHR)-based home BP with telemonitoring combined with co-interventions has been shown to lower BP more effectively than the traditional approach based on office BP. Thus, home BP represents a key metric for personalized anticipation medicine, from digital healthcare to digital medicine. This paper summarizes the latest evidence on home BP monitoring and proposes a Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network consensus on a home BP-centered approach to the management of hypertension. [Figure not available: see fulltext.]
AB - Recent innovations in digital technology have enabled the simultaneous accumulation, and the linking and analysis of time-series big data relating to several factors that influence blood pressure (BP), including biological indicators, physical activity, and environmental information. Various approaches can be used to monitor BP: in the office/clinic; at home; 24-h ambulatory recording; or with wearable and cuffless devices. Of these, home BP monitoring is a reliable and convenient method, and is recommended for hypertension management by current national and international guidelines. This recommendation is based on evidence showing that home BP is an important predictor of cardiovascular, cerebrovascular and kidney disease in patients with hypertension. In addition, lifetime personalized health record (PHR)-based home BP with telemonitoring combined with co-interventions has been shown to lower BP more effectively than the traditional approach based on office BP. Thus, home BP represents a key metric for personalized anticipation medicine, from digital healthcare to digital medicine. This paper summarizes the latest evidence on home BP monitoring and proposes a Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network consensus on a home BP-centered approach to the management of hypertension. [Figure not available: see fulltext.]
KW - Anticipation medicine
KW - Digital health
KW - HOPE Asia Network
KW - Home blood pressure
KW - Personalized health record
KW - Personalized medicine
UR - http://www.scopus.com/inward/record.url?scp=85168449811&partnerID=8YFLogxK
U2 - 10.1038/s41440-023-01397-6
DO - 10.1038/s41440-023-01397-6
M3 - Review article
C2 - 37605071
AN - SCOPUS:85168449811
SN - 0916-9636
VL - 46
SP - 2561
EP - 2574
JO - Hypertension Research
JF - Hypertension Research
IS - 12
ER -